Enliven Therapeutics to Present at Upcoming Investor Conferences

BURLINGAME, Calif., Sept. 3, 2026 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced that management will participate in the following investor conferences:

Wells Fargo 21st Annual Healthcare Conference
Date: Tuesday, Sept. 8, 2026
Location: Boston, MA
Forum: 1x1 Meetings

Baird 2026 Global Healthcare Conference
Date: Tuesday, Sept. 15, 2026
Location: New York, NY
Forum: Fireside Chat and 1x1 Meetings

Morgan Stanley 24th Annual Global Healthcare Conference
Date: Wednesday, Sept. 16, 2026
Location: New York, NY
Forum: Fireside Chat and 1x1 Meetings

A live webcast of the Morgan Stanley fireside chat will be available in the Investor Relations section of the Company's website at https://ir.enliventherapeutics.com/. A replay of the webcast will be archived on the Company's website for 90 days following the conclusion of the presentation.

About Enliven Therapeutics
Enliven is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics to help people not only live longer, but live better. Enliven aims to address existing and emerging unmet needs with a precision medicine approach that improves survival and enhances overall well-being. Enliven's discovery process combines deep insights into clinically validated biological targets and differentiated chemistry to design potentially first-in-class or best-in-class therapies. To learn more, visit www.enliventherapeutics.com and connect with us on LinkedIn and X.

View original content to download multimedia:https://www.prnewswire.com/news-releases/enliven-therapeutics-to-present-at-upcoming-investor-conferences-302869431.html

SOURCE Enliven Therapeutics, Inc.